-
effectivehealthcare.ahrq.gov/sites/default/files/comparator-selection-in-observational-chapter-5.pptx
January 01, 2013 - Confounding by indication or severity:
Medications may be used for patients with a milder disease, and … However, pharmacy dispensing does not provide information on the actual intake of medications by patients … Adherence to Drugs and Device Failure or Removal
Patients who are on medications could have various degrees … of adherence from completely stopping, to skipping doses, to taking medications as prescribed.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/gout_research-protocol.pdf
November 03, 2014 - Certain medications also may increase
the risk for developing gout (e.g., thiazide diuretics). … to office visits for acute flares, and 61 percent were attributed to
expenditures for prescription medications … Key Question 5: Discontinuation of Pharmaceutical Management for Patients on
Acute or Chronic Gout Medications … : allopurinol, febuxostat)
(KQ3, 5)
• Uricosuric agents (probenecid) (KQ3, 5a)
§ Combination medications
-
effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1312.pdf
December 01, 2013 - Medications that address to the
underlying cause(s) of social deficits of ASD during early childhood … become the standard of care
for treating social dysfunction in ASDs, because of the absence of other medications … and medical interventions used to control autism symptoms include antidepressants,
antipsychotic medications … However, at
this time, no medications are available that address and improve ASD core symptoms, including
-
effectivehealthcare.ahrq.gov/sites/default/files/s38.pdf
October 01, 2007 - data for the potentially eligible patients in this trial contained
information on use of osteoporosis medications … 997 976 —
Age, yr, median (IQR) 68 (65–72) 69 (66–74) 0.004
Female, N (%) 895 (90) 922 (94) 0.001
Medications … automated data sets may
be optimal for assessment of history of system use, prior diag-
noses, and use of medications … . 1010 963 —
Age, yr, median (IQR) 69 (66–73) 68 (65–73) 0.5
Female, N (%) 936 (93) 881 (91) 0.4
Medications
-
effectivehealthcare.ahrq.gov/products/rheumatoid-arthritis-medicine-update/research-protocol
May 24, 2017 - Administration (FDA)–approved drugs for RA
Group
Names
a FDA is currently evaluating for approval b New medications … pregnancy), and (4) the role of newly approved drugs in the treatment strategies in the context of older medications … the following: study design, eligibility criteria, intervention (drugs, dose, duration), additional medications … Additionally, as a practicing rheumatologist, she prescribes all the medications included in this review … If her published studies on RA medications are potentially eligible for this review, Dr.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/uterine-fibroids_research-protocol.pdf
March 01, 2016 - Source: www.effectivehealthcare.ahrq.gov
Published online: March 1, 2016
2
No medications have … Food and Drug
Administration (FDA) for treatment of fibroid symptoms, though several medications are … Ablative procedures (e.g., MRgFUS, cryoablation);
• Progestin-containing intrauterine devices;
• Medications … information from stakeholders,
including Scientific Information Packets (SIP) and regulatory information on
medications … Medications for uterine fibroid treatment
Drug Category
Drug Name
Brand/Other Names
Labeled
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_executive.pdf
September 01, 2011 - Antidepressant medications, which
are the most commonly used intervention, have
decreasing efficacy for … this report):
studies in which patients specifically had two or
more prior treatment failures with medications … severity (9 points by HAM-D) and significantly better
response rates (71 percent vs. 28 percent) than
medications … Also, given that treatment options for many TRD
patients include medications, trials should directly … patients continue with
atypical antipsychotics, some with mood stabilizers,
some with no psychotropic medications—results
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-liver-metastases-therapies_executive.pdf
December 01, 2012 - 1
Comparative Effectiveness Review
Number 93
Local Hepatic Therapies for Metastases to the
Liver From Unresectable Colorectal Cancer
Executive Summary
Background
This report aims to compare the
effectiveness and harms of several
local hepatic therapies for unresectable
colorectal cancer (CRC) metastases to
…
-
effectivehealthcare.ahrq.gov/products/plasma-cell-dyscrasias-sflc-assay/research-protocol
May 02, 2011 - Current Page Topic Timeline Jun. 17, 2009 Topic Suggestion May. 2, 2011 Research Protocol Aug. 23, 2012 Systematic Review Jun. 28, 2013 Disposition of Comments Report Serum-Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias
Research Protocol Archived May 2, 2011 Downlo…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cesarean-birth-2010_research-protocol.pdf
January 01, 2010 - Evidence-based Practice Center Systematic Review Protocol
Source: www.effectivehealthcare.ahrq.gov
Published Online: May 6, 2011
Evidence-based Practice Center Systematic Review Protocol
Project Title: Strategies To Reduce Cesarean
I. Background and Objectives for the Systematic Review
Recent rep…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/wireless-motility-capsule_executive.pdf
May 01, 2013 - Medications that commonly cause gastric emptying
delay are opiates or glucagon-like peptide agonists … Other outcomes
include the ability of testing to influence treatment
decisions (e.g., changes in medications … Medical management
includes avoiding constipating medications and initiating
bulking agents (e.g., … There were no language
Treatment Decisions
• Change in
medications
• Change in nutrition
• Surgery … We had included patient
outcomes (need for medications, additional tests) as
outcomes in our review
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/anal-cancer-draft-report.pdf
October 31, 2023 - Treatment of Stages I-III Squamous Cell Anal Cancer: A Systematic Review
i
Draft Comparative Effectiveness Review
Number xx
Treatment of Stages I-III Squamous Cell Anal Cancer:
A Systematic Review
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
5…
-
effectivehealthcare.ahrq.gov/products/omega-3-maternity/research-protocol
May 18, 2015 - Current Page Topic Timeline May. 16, 2015 Topic Initiated May. 18, 2015 Research Protocol Oct. 12, 2016 Systematic Review Feb. 9, 2017 Disposition of Comments Report Omega 3 Fatty Acids and Maternal and Child Health
Research Protocol Archived May 18, 2015 Download Main Document PDF 541.5 KB
Archived:…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/people-with-disabilities-protocol.pdf
January 16, 2024 - Healthcare Delivery of Clinical Preventive Services for People with Disabilities
Evidence-based Practice Center Systematic Review Protocol
Project Title: Healthcare Delivery of Clinical Preventive Services for People with Disabilities
Publication Date: October 24, 2023
Amendment Date: December 15, 2023. J…
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/pbi-protocol.pdf
August 09, 2021 - Partial Breast Irradiation for Breast Cancer: Systematic Review Protocol
Evidence-based Practice Center Systematic Review Protocol
Project Title: Partial Breast Irradiation for Breast Cancer
I. Background and Objectives for the Systematic Review
With an estimated 2.3 million new cases in 2020, breast canc…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-abnormalities-tests_appendixes.pdf
May 23, 2005 - Effectiveness of Noninvasive Diagnostic Tests for Breast Abnormalities Appendices
Appendix A. Literature Search Strategies
Literature Search Strategies
Electronic Database Searches
The following databases have been searched for relevant information:
ClinicalTrials.gov (through April 2005)
Cochrane Data…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-machine-learning-screening.pdf
November 01, 2019 - Methods Research Report: Performance and Usability of Machine Learning for Screening in Systematic Reviews
Methods Research Report
Performance and Usability of Machine Learning for
Screening in Systematic Reviews: A Comparative
Evaluation of Three Tools
Methods Research Report
Performance and Usability of Ma…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rotator-cuff-tears-future_research.pdf
February 01, 2013 - FRN 39 - Nonoperative and Operative Treatments for Rotator Cuff Tears: Future Research Needs
Future Research Needs Paper
Number 39
Nonoperative and
Operative Treatments for
Rotator Cuff Tears: Future
Research Needs
Future Research Needs Paper
Number 39
Nonoperative and Operative Treatments for Rotator
Cuf…
-
effectivehealthcare.ahrq.gov/system/files/docs/benefits_pulmonary_rehab_topic_brief.pdf
October 28, 2020 - Topic Brief: Benefits of Pulmonary Rehabilitation
1
Topic Brief: Benefits of Pulmonary Rehabilitation
Date: 10/28/2020
Nomination Number: 0921
Purpose: This document summarizes the information addressing a nomination submitted on
July 16, 2020 through the Effective Health Care Website. This informati…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/nephropathy-contrast-induced_executive-2016.pdf
January 01, 2016 - 1
Comparative Effectiveness Review
Number 155
Contrast-Induced Nephropathy: Comparative
Effects of Different Contrast Media
Executive Summary
Background
The administration of iodinated contrast
media is an essential component of many
diagnostic and therapeutic procedures
that involve radiologic imaging. An
i…